COVID-19患者出院后血栓形成与出血情况
该回顾性观察性队列研究纳入163例确诊COVID-19且出院时未接受抗凝治疗的患者,出院至末次随访中位时间30天,出院后30天血栓累积发生率为2.5%(95%CI 0.8-7.6),静脉血栓栓塞为0.6%(95%CI 0.1-4.6),大出血为0.7%(95%CI 0.1-5.1),临床相关非大出血为2.9%(95%CI 1.0-9.1)。作者结论认为出院后血栓与出血发生率相近,强调需要随机数据以指导出院后普遍血栓预防的建议。
要点
- 出院后30天血栓累积发生率为2.5%(95%CI 0.8-7.6),静脉血栓栓塞为0.6%(95%CI 0.1-4.6)。
- 出院后30天大出血累积发生率为0.7%(95%CI 0.1-5.1),临床相关非大出血为2.9%(95%CI 1.0-9.1)。
- 作者认为血栓与出血发生率相近,强调需要随机数据以指导出院后普遍血栓预防的建议。
核心结论
- 作者结论认为COVID-19出院后血栓形成与出血的发生率似乎相近,强调需要随机数据以指导出院后普遍血栓预防的建议。
研究设计与样本
- 回顾性观察性队列研究,纳入163例确诊COVID-19且出院时未接受抗凝治疗的患者。
主要发现
- 出院至末次随访中位时间30天(IQR 17-46天),指数住院中位时长6天(IQR 3-12天),26%需重症监护。
- 出院后30天血栓(含动脉和静脉事件)累积发生率为2.5%(95%CI 0.8-7.6)。
- 出院后30天单纯静脉血栓栓塞累积发生率为0.6%(95%CI 0.1-4.6)。
- 出院后30天大出血累积发生率为0.7%(95%CI 0.1-5.1),临床相关非大出血为2.9%(95%CI 1.0-9.1)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state with a high incidence of thrombotic events during hospitalization; however, data examining rates of thrombosis after discharge are limited. We conducted a retrospective observational cohort study of discharged patients with confirmed COVID-19 not receiving anticoagulation. The cohort included 163 patients with median time from discharge to last recorded follow-up of 30 days (interquartile range [IQR], 17-46 days). The median duration of index hospitalization was 6 days (IQR, 3-12 days) and 26% required intensive care. The cumulative incidence of thrombosis (including arterial and venous events) at day 30 following discharge was 2.5% (95% confidence interval [CI], 0.8-7.6); the cumulative incidence of venous thromboembolism alone at day 30 postdischarge was 0.6% (95% CI, 0.1-4.6). The 30-day cumulative incidence of major hemorrhage was 0.7% (95% CI, 0.1-5.1) and of clinically relevant nonmajor bleeds was 2.9% (95% CI, 1.0-9.1). We conclude that the rates of thrombosis and hemorrhage appear to be similar following hospital discharge for COVID-19, emphasizing the need for randomized data to inform recommendations for universal postdischarge thromboprophylaxis.
引用
- Patell R, Bogue T, Koshy A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020. PMID: 32766883. doi:10.1182/blood.2020007938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。